A Grading System for Invasive Pulmonary Adenocarcinoma: A Proposal From the International Association for the Study of Lung Cancer Pathology Committee. Academic Article uri icon

Overview

abstract

  • INTRODUCTION: A grading system for pulmonary adenocarcinoma has not been established. The International Association for the Study of Lung Cancer pathology panel evaluated a set of histologic criteria associated with prognosis aimed at establishing a grading system for invasive pulmonary adenocarcinoma. METHODS: A multi-institutional study involving multiple cohorts of invasive pulmonary adenocarcinomas was conducted. A cohort of 284 stage I pulmonary adenocarcinomas was used as a training set to identify histologic features associated with patient outcomes (recurrence-free survival [RFS] and overall survival [OS]). Receiver operating characteristic curve analysis was used to select the best model, which was validated (n = 212) and tested (n = 300, including stage I-III) in independent cohorts. Reproducibility of the model was assessed using kappa statistics. RESULTS: The best model (area under the receiver operating characteristic curve [AUC] = 0.749 for RFS and 0.787 for OS) was composed of a combination of predominant plus high-grade histologic pattern with a cutoff of 20% for the latter. The model consists of the following: grade 1, lepidic predominant tumor; grade 2, acinar or papillary predominant tumor, both with no or less than 20% of high-grade patterns; and grade 3, any tumor with 20% or more of high-grade patterns (solid, micropapillary, or complex gland). Similar results were seen in the validation (AUC = 0.732 for RFS and 0.787 for OS) and test cohorts (AUC = 0.690 for RFS and 0.743 for OS), confirming the predictive value of the model. Interobserver reproducibility revealed good agreement (k = 0.617). CONCLUSIONS: A grading system based on the predominant and high-grade patterns is practical and prognostic for invasive pulmonary adenocarcinoma.

authors

  • Moreira, Andre L
  • Ocampo, Paolo S S
  • Xia, Yuhe
  • Zhong, Judy
  • Russell, Prudence A
  • Minami, Yuko
  • Cooper, Wendy A
  • Yoshida, Akihiko
  • Bubendorf, Lukas
  • Papotti, Mauro
  • Pelosi, Giuseppe
  • Lopez-Rios, Fernando
  • Kunitoki, Keiko
  • Ferrari-Light, Dana
  • Sholl, Lynette M
  • Beasley, Mary Beth
  • Borczuk, Alain
  • Botling, Johan
  • Brambilla, Elisabeth
  • Chen, Gang
  • Chou, Teh-Ying
  • Chung, Jin-Haeng
  • Dacic, Sanja
  • Jain, Deepali
  • Hirsch, Fred R
  • Hwang, David
  • Lantuejoul, Sylvie
  • Lin, Dongmei
  • Longshore, John W
  • Motoi, Noriko
  • Noguchi, Masayuki
  • Poleri, Claudia
  • Rekhtman, Natasha
  • Tsao, Ming-Sound
  • Thunnissen, Erik
  • Travis, William David
  • Yatabe, Yasushi
  • Roden, Anja C
  • Daigneault, Jillian B
  • Wistuba, Ignacio I
  • Kerr, Keith M
  • Pass, Harvey
  • Nicholson, Andrew G
  • Mino-Kenudson, Mari

publication date

  • June 17, 2020

Research

keywords

  • Adenocarcinoma
  • Lung Neoplasms

Identity

PubMed Central ID

  • PMC8362286

Scopus Document Identifier

  • 85087929399

Digital Object Identifier (DOI)

  • 10.1016/j.jtho.2020.06.001

PubMed ID

  • 32562873

Additional Document Info

volume

  • 15

issue

  • 10